MRSA was once eradicated reliably by vancomycin (Vancocin AE), an antibiotic of the glycopeptide class. With time, the MRSA bacteria became resistant to vancomycin and vancomycin-resistant ...

Vancomycin 265/309 (85.8%) 76/265 (25.3%) 198/309 (64.1%) † Clinical cure is resolution of diarrhea following the recommended dose of drug (fidaxomicin: 200 mg twice a day; vancomycin ...

None of these patients had a rise in the platelet count until the vancomycin was discontinued and an alternative antibiotic started. The vancomycin was stopped early in the remaining 14 patients ...

Anti-anaerobic antibiotic treatment was associated with ... (Patients with repeated admissions, who did not receive ...

The peptide material was tested in bacterial cultures, in combination with two different antibiotics: oxacillin and vancomycin. The bacteria included in the experiments were two types of ...

The growth of the vancomycin market is driven by several key factors, including the increasing prevalence of antibiotic-resistant infections, advancements in pharmaceutical manufacturing ...

Immuron Limited (IMRN), an Australian-based biopharmaceutical company, Wednesday, announced a new research collaboration with Monash ...

Highlights: New Research Collaboration with Monash University One proposal will target Antimicrobial Resistant Pathways to develop broad spectrum therapeutic drug productsSecond project proposal will ...

Antibiotics such as vancomycin require careful monitoring and dosing regimens that take into account patient-specific factors impacted by the drug’s pharmacokinetics and pharmacodynamics ...